Palmer Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -9.09%
- Profit Growth 14.65%
- Ebitda -45.09%
- Net Worth 16.72%
- Total Assets 11.31%
About Palmer Laboratories
Palmer Laboratories Private Limited (PLPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 August 2005 and has a history of 19 years and five months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priyal Shah and Vikrambhai Vakil serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ2005PTC046683
-
Company No.
046683
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Aug 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Palmer Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyal Shah
|
Whole-Time Director | 31-Aug-2005 | Current |
|
Vikrambhai Vakil
|
Whole-Time Director | 31-Aug-2005 | Current |
Financial Performance of Palmer Laboratories.
Palmer Laboratories Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 9.09% decrease. The company also saw a substantial improvement in profitability, with a 14.65% increase in profit. The company's net worth Soared by an impressive increase of 16.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Palmer Laboratories?
In 2019, Palmer Laboratories had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Skyline Herbals Private LimitedPriyal Shah is a mutual person
-
Lykis Herbals Private Limited
Priyal Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Palmer Laboratories?
Unlock and access historical data on people associated with Palmer Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Palmer Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Palmer Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
